$CTAS

Is Cintas Stock Underperforming the Nasdaq?

ABM Industries (ABM) outperformed Cintas (CTAS) year-to-date with an 11.7% gain, but CTAS has a 'Moderate Buy' rating and $217.44 average price target, implying 8.2% upside.

Original reporting
Published Sep 4, 2026, 2:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 5, 2026, 6:42 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Cintas Stock Underperforming the Nasdaq? — source image
Decision brief

The 30-second read

$CTASBullishLow
01

Why it matters

Analyst price target provides a modest upside view but lacks a fresh catalyst.

02

Market read

Limited impact; primarily an analyst opinion piece.

03

What to watch

No recent earnings or catalyst disclosed; rating may be based on outdated data.

Relevance 5/10Novelty 4/10Timing: current

Background

The article compares Cintas (CTAS) to ABM Industries (ABM) and notes analyst consensus.

Company-level read

Ticker impact

$CTASBullishMedium confidence
Context

Analysts set a consensus "Moderate Buy" rating with a mean price target of $217.44, implying an 8.2% upside.

Expected impact

Small upside if price moves toward target.

Evidence & confidence

The price target suggests limited upside; traders may consider a small long position.

Market effects

Specialty business services sector may see modest interest.

U.S. market, limited broader effect.

Low

Counterpoint

Target may be overly optimistic given recent performance.

Key entities

  • Cintas Corporation

    Subject of analyst rating and price target.

  • ABM Industries Incorporated

    Mentioned for performance comparison only.

Related articles

$CTASHighAI 8/10

Wells Fargo maintains Overweight on Cintas, raises target to $250

Cintas reported Q4 2026 revenue of $2.91B, up 8.9%, and EPS of $1.29, beating estimates. Full-year revenue was $11.26B, up 8.9%. The company guided fiscal 2027 revenue to $12.1B-$12.25B and EPS to $5.36-$5.50. Wells Fargo raised its target to $250, and other analysts also increased price targets. Shares rose 2.9% in pre-market trading.

$CTASMed

Cintas-UniFirst deal spread widens on FTC scrutiny: Bernstein

Bernstein notes increased market concern over Cintas's (CTAS) acquisition of UniFirst (UNF) due to FTC scrutiny. The spread between the two stocks has widened, with UniFirst shares dropping 7% and Cintas down 2% since August 25. Analyst Connor Cerniglia rates Cintas Market Perform with a $200 price target, citing a 30% chance of deal failure. Cintas expects to complete its FTC response by November, with Bernstein believing the deal will likely close in early 2027.

$CTASMed

RBC Thinks Cintas Has Room To Raise Its Outlook

RBC raised Cintas' EPS forecast to $5.40-$5.55 and increased its revenue range, citing easier comparisons and solid execution. However, RBC noted fuel costs as a potential pressure and maintained a 'sector perform' rating and $206 price target, suggesting limited upside without improved profitability.

$VMed

Donald Trump makes over 1,000 securities trades in June, buys Berkshire Hathaway, Visa, Mastercard, and Cintas

Donald Trump's June financial disclosure shows 1,051 trades, with purchases exceeding $49M and sales of at least $28.5M. Notable buys include Berkshire Hathaway, Visa, Mastercard, and Cintas, while Meta Platforms and Motorola were sold. The largest transaction was a $5M-$25M sale of VIG ETF. Trump's accounts made 21,000 trades in 2025, managed by his children. The June 18 trades followed a market selloff triggered by a Federal Reserve meeting.

$CTASMed

Cintas (CTAS) Could Be 3% Below Fair Value After Strong Results And Guidance

Simply Wall St reports Cintas (CTAS) posted higher Q4 and full-year sales, revenue, and net income, and issued fiscal 2027 revenue guidance of US$12.10b to US$12.25b. The stock rose after results, trading at about US$205.91 versus a fair value estimate near US$212.41, implying roughly 3% undervaluation, with valuation risks tied to uniform demand and margins.